Yicha - MaaT Pharma Announces First DSMB Positive Review of Ongoing Phase 2 Clinical Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT

Article: https://www.marketscreener.com/quote/stock/MAAT-PHARMA-128358114/news/MaaT-Pharma-Announces-First-DSMB-Positive-Review-of-Ongoing-Phase-2-Clinical-Trial-Evaluating-MaaT03-47287565/?utm_medium=RSS&utm_content=20240702